Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors

被引：0
|
作者：
Carol H. Wysham
Patrick Lefebvre
Dominic Pilon
Mike Ingham
Marie-Hélène Lafeuille
Bruno Emond
Rhiannon Kamstra
Wing Chow
Michael Pfeifer
Mei Sheng Duh
机构：
[1] Rockwood Clinic,
[2] Groupe d’analyse,undefined
[3] Ltée,undefined
[4] Janssen Scientific Affairs,undefined
[5] LLC,undefined
[6] Johnson & Johnson,undefined
[7] Analysis Group,undefined
[8] Inc.,undefined
来源：
BMC Endocrine Disorders | / 17卷
关键词：
Canagliflozin; Type 2 diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; HbA1c; Blood pressure; Weight loss;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Xin Wei
    Yu Bai
    Zhuo Wang
    Xiaohong Zheng
    Zening Jin
    Xin Liu
    Diabetology & Metabolic Syndrome, 13
  • [22] The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
    Yousefzadeh, Pegah
    Wang, Xiangbing
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [23] Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus
    Li, Ning
    Wang, Li-Jun
    Jiang, Bo
    Li, Xiang-qian
    Guo, Chuan-long
    Guo, Shu-ju
    Shi, Da-Yong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 145 - 157
  • [24] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2015, 20 (01) : 64 - 66
  • [25] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    PharmacoEconomics, 2015, 33 : 581 - 597
  • [26] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [27] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
  • [28] Use of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
    Mikhail, Nasser
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 138 - 144
  • [29] Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 117 - 118
  • [30] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (06) : 508 - 510
12345